Last updated on June 2018

A Study of Levetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Subjects Ranging From 1 Month to Less Than 4 Years of Age


Brief description of study

This is a study to confirm the efficacy of Levetiracetam as adjunctive treatment in pediatric epilepsy subjects aged 1 month to less than 4 years of age with partial seizures.

Clinical Study Identifier: NCT03340064

Contact Investigators or Research Sites near you

Start Over

UCB Cares

Ep0100 015
Fukuoka, Japan
  Connect »

UCB Cares

Ep0100 003
Hamamatsu, Japan
  Connect »

UCB Cares

Ep0100 006
Izumi, Japan
  Connect »

UCB Cares

Ep0100 002
Kodaira, Japan
  Connect »

UCB Cares

Ep0100 007
Koshi, Japan
  Connect »

UCB Cares

Ep0100 009
Nagakute, Japan
  Connect »

UCB Cares

Ep0100 005
Niigata, Japan
  Connect »

UCB Cares

Ep0100 012
Obu, Japan
  Connect »

UCB Cares

Ep0100 014
Okayama, Japan
  Connect »

UCB Cares

Ep0100 013
Osaka, Japan
  Connect »

UCB Cares

Ep0100 018
Saitama, Japan
  Connect »

UCB Cares

Ep0100 004
Sapporo, Japan
  Connect »

UCB Cares

Ep0100 010
Sendai, Japan
  Connect »

UCB Cares

Ep0100 016
Shinjuku-ku, Japan
  Connect »

UCB Cares

Ep0100 001
Shizuoka, Japan
  Connect »

UCB Cares

Ep0100 008
Suita, Japan
  Connect »

UCB Cares

Ep0100 017
Tokyo, Japan
  Connect »